Results 131 to 140 of about 74,203 (313)

Angiographic estimation of atherosclerotic disease burden in a coronary artery fed by collaterals: a potential pitfall in decision for revascularization

Vascular Health and Risk Management, 2011
Grigorios Tsigkas, Panagiota Mylona, Periklis Davlouros, Dimitrios AlexopoulosCardiology Department, University Hospital of Patras, Patras, GreeceAbstract: Despite the remarkable advances in revascularization strategies made during the last decade, a ...
Tsigkas G, Mylona P, Davlouros P, Alexopoulos D   +3 more
doaj  

The Effect of Treatment Strategy of Chronic Ischemic Mitral Regurgitation on Long-Term Outcomes in Coronary Artery Bypass Grafting

Brazilian Journal of Cardiovascular Surgery
Objective: To investigate the mid- and long-term outcomes of case-based selective strategy of mitral ring annuloplasty during coronary artery bypass grafting in patients with coronary artery disease accompanied by chronic ischemic mitral regurgitation ...
Hüseyin Şaşkin, Kazım Serhan Ozcan, Mustafa İdiz   +2 more
doaj   +1 more source

Cardiotoxicity of BRAF/MEK inhibitors

British Journal of Pharmacology, EarlyView.
Abstract Rapidly accelerated fibrosarcoma type B/B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) and mitogen‐activated protein kinase (MEK) inhibitors have transformed outcomes in cancer therapy, particularly in melanoma. However, cardiovascular toxicities are increasingly recognized in real‐world clinical practice.
Katharina Seuthe, Valerie Lohner, Kevin Terre, Thomas Riffelmacher, Roman Pfister   +4 more
wiley   +1 more source

Bilateral internal thoracic artery grafting in isolated coronary artery bypass grafting: A 35-year experienceCentral MessagePerspective

JTCVS Open
Objectives: The study objectives were to analyze trends in bilateral internal thoracic artery grafting during isolated coronary artery bypass grafting over a 35-year interval and compare outcomes between bilateral internal thoracic artery and non ...
Youssef Shahin, MD, Tedy Sawma, MD, Yazan AlJamal, MD, Arman Arghami, MD, MPH, Phillip Rowse, MD, Hartzell Schaff, MD, Richard C. Daly, MD, Lorenzo Knop, John Stulak, MD   +8 more
doaj   +1 more source

Improvement in quality of life during 5 years after coronary artery bypass grafting

, 1998
To describe the changes in various aspects of quality of life (QOL) from before coronary artery bypass grafting (CABG) to 5 years after the ...
Wiklund, I, Caidahl, Kenneth,, Herlitz, Johan,, Karlsson, Thomas,, Haglid Evander, Maria,, Sjöland, Helen,, Karlson, Björn W.,   +6 more
core  

Coronary artery bypass grafting without cardiopulmonary bypass

, 1996
Background. Coronary artery bypass grafting without cardiopulmonary bypass is now an accepted technique of myocardial revascularization. We herein report our total experience with this procedure.Methods. in a consecutive series of 8,751 patients operated
deAndrade, JCS, Branco, JNR, Buffolo, E., Gomes, Walter José [UNIFESP], Teles, C. A., Aguiar, L. F.   +5 more
core   +1 more source

Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double‐Blind Phase II Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim This study aimed to evaluate its safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy in Chinese adults with T2DM and to preliminarily compare its efficacy and safety with semaglutide through multiple subcutaneous injections. Materials and Methods In this multicentre, randomised, placebo‐controlled and semaglutide‐positive‐
Ping Jin, Linong Ji, Yangqing Huang, Haifeng Ding, Daosheng Xie, Xiaohui Jiang, Xuemei Yuan, Zhao Cao, Haibin Zhang, Jiandong Yuan   +9 more
wiley   +1 more source

Management of a Case of von Hippel-Lindau for Coronary Artery Bypass Grafting

, 2015
von Hippel-Lindau (VHL) disease is a rare autosomal dominant genetic disorder with retinal and nervous system haemangioblastomas, phaeochromocytoma, renal, pancreatic and endolymphatic tumours.
Geetanjali S. Verma
core  

What Is a Clinically Meaningful Change in Diabetes Distress? Findings for Diabetes Care and Research From the SFDT1 Cohort

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Diabetes distress (DD) is common and evolves heterogeneously over time. We aimed to estimate minimal clinically important differences (MCID) for the Problem Areas in Diabetes (PAID) scale and its sub‐dimensions and to identify predictors of worsening over 1 year in people with type 1 diabetes (PwT1D).
Dulce Canha, Jean‐Pierre Riveline, Fatima Kazanlieva, Gloria A. Aguayo, Charline Bour, Bruno Vergès, Pierre‐Yves Benhamou, Michaël Joubert, Fawaz Alzaid, Emmanuel Cosson, Guy Fagherazzi   +10 more
wiley   +1 more source

Coronary artery bypass grafting versus percutaneous intervention in coronary revascularization: a historical perspective and review

, 2015
Sonya N Burgess,1 John J Edmond,2 Craig P Juergens,1 John K French11Department of Cardiology, Liverpool Hospital and South Western Sydney Clinical School, The University of New South Wales, Sydney, NSW, Australia; 2Department of Cardiology, Dunedin ...
Juergens CP, Edmond JJ, Burgess SN, French JK   +3 more
core